DR. SHWETA SHARMA

Qualification: M.D. (Pathology) ,M.B.B.S.

Designation / Role: Professor and Quality Manager in Blood Centre, Dept of IHBT at MGMCH, Jaipur

Specialty: Pathology

Associated MLH Pages: Anticoagulation Summit– Building Expertise in Anticoagulation Management See Less

Dr. Shweta Sharma is a Professor, Medical Officer, and Quality Manager in Immunohematology and Blood Transfusion (MD Pathology) at MGUMST, Jaipur, who was a key Co-investigator in the ICMR Placid Trial for COVID-19 and is recognized for her academic and quality management contributions.

Education & Qualification

M.D. (Pathology)
M.B.B.S.
Completed a short course in Hepatopathology from ILBS, New Delhi (2016).
Completed training in Quality Management Systems and Internal Audit in Medical Labs as per ISO 15189 -2012 (2018).
Completed a course on HLA (Human Leukocyte Antigen) conducted under the aegis of the Indian Society of Blood Transfusion Immunohematology.

Professional Profile

Present Position: Professor, Medical Officer (MO), and Quality Manager (QM) in the Department of Immunohematology and Blood Transfusion (IHBT) at Mahatma Gandhi University of Medical Sciences & Technology (MGUMST), Jaipur (since June 2023).
Prior Roles: Served as Associate Professor (Nov 2019–May 2023) and Assistant Professor (July 2015–Nov 2019) in the same department at MGUMST, Jaipur.

Awards & Honors

Awarded as Best Oral Paper at the "International Dermatopathology Conference 2013".
Appreciation Award for NABH accreditation at Mahatma Gandhi Hospital (2019).
Appreciation Award for Corona Warrior at Mahatma Gandhi Hospital (2020).
Appreciation Award on Women’s Day and a Certificate of Excellence on 26th January at MGUMST.

Publications

Co-author of the ICMR Placid Trial published in BMJ (2020) on the effectiveness of convalescent plasma for moderate Covid 19 in adults in India.
Authored/co-authored papers on the Association of hematological parameters with disease severity in Covid 19 patients.
Published a study on the Seroprevalence of SARS-CoV-2 IgG antibody among healthy blood donors.
Published research on Autoimmune Hemolytic Anemia after Allogeneic Stem Cell Transplantation.

Achievements

Served as a Co-investigator in the ICMR Placid Trial (A phase II Open label randomized controlled trial to assess the safety and efficacy of convalescent plasma to limit Covid 19 associated complications in moderate diseases) in 2020.
Instrumental in NABH accreditation efforts at Mahatma Gandhi Hospital.
Completed advanced training in Medical Education Technologies (MET) and Quality Management Systems (ISO 15189) for medical labs